Tulay Eren (Tülay Eren)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Monoclonal Antibody

Locally Advanced

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Infectious diseases & clinical microbiology

Future oncology (London, England)

Journal of gastrointestinal cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Halime Araz, Tulay Eren, Aysel Kocagül Çelikbaş, Nuriye Ozdemir
Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy. Infectious diseases & clinical microbiology 4 (4) (2022)
Halime Araz, Tulay Eren, Aysel Kocagül Çelikbaş, Nuriye Ozdemir
Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy. Infectious diseases & clinical microbiology 4 (4) (2022)
Cengiz Karaçin, Tulay Eren, Esra Zeynelgil, Goksen İnanc İmamoglu, Mustafa Altınbaş, Ibrahim Karadag, Fatma Bugdayci Basal, Hasan Selçuk Özger, Osman Sütçüoğlu, Ozan Yazıcı, Nuriye Ozdemir, Ahmet Özet, Yeşim Yıldız, Selin Aktürk Esen, Gokhan Ucar, Doğan Uncu, Bedia Dinc, Musa Baris Aykan, İsmail Ertürk, Nuri Karadurmus, Burak Civelek, İsmail Çelik, Yakup Ergün, Mutlu Doğan, Ömür Berna Çakmak Öksüzoğlu
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Future oncology (London, England) 17 (33) (2021)
Ismail Beypinar, Hacer Demir, Abdullah Sakin, Burcu Yapar Taşköylü, Teoman Sakalar, Yakup Ergün, Mustafa Korkmaz, Ozturk Ates, Tulay Eren, Nazım Serdar Turhal, Mustafa Yıldırım
The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study. Journal of gastrointestinal cancer (2020)
Tulay Eren, Cengiz Karaçin, Gokhan Ucar, Yakup Ergün, Ozan Yazıcı, Goksen İnanc İmamoglu, Nuriye Ozdemir
Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients. Medicine 99 (22) (2020)